The global Insulin (API & Injection) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Insulin (API & Injection) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin (API & Injection) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Insulin (API & Injection) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Insulin (API & Injection) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novo Nordisk
Eli Lilly
Sanofi-Aventis
Dongbao
Bioton
United Laboratories
Merck
Ganlee

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Animal Insulin
Human Insulin
Insulin Analogue

Segment by Application
Diabetes
Coronary Heart Disease
Perioperation Period
Others